Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea

Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea

ObjectiveTo compare the incidence and survival rates of primary ovarian clear cell carcinoma (OCCC) and ovarian serous carcinoma (OSC) from a nationwide collected database.MethodsWe extracted information of patients with primary OCCC and OSC from the Korea Central Cancer Registry recorded between 19...

Descripció completa

Dades bibliogràfiques
Autors principals:	Se Ik Kim, Hyeong In Ha, Kyung Jin Eoh, Jiwon Lim, Young-Joo Won, Myong Cheol Lim
Format:	Article
Idioma:	English
Publicat:	Frontiers Media S.A. 2022-04-01
Col·lecció:	Frontiers in Oncology
Matèries:	ovarian cancer histologic subtype clear cell carcinoma serous carcinoma incidence survival
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2022.874037/full

Ítems similars

Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
per: Huimei Zhou, et al.
Publicat: (2020-04-01)

Testicular serous carcinoma of ovarian epithelial type
per: Chang-Hong Yeh, et al.
Publicat: (2017-06-01)

Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
per: Kosuke Kanno, et al.
Publicat: (2024-08-01)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
per: Maho Shimizu, et al.
Publicat: (2021-06-01)

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
per: Manon Lefebvre, et al.
Publicat: (2023-01-01)

Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer
per: Jung Mi Byun, et al.
Publicat: (2023-01-01)

Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database
per: Xiaoduo Li, et al.
Publicat: (2021-02-01)

Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma
per: Ruifen Dong, et al.
Publicat: (2016-09-01)

Nomograms of Combining MRI Multisequences Radiomics and Clinical Factors for Differentiating High-Grade From Low-Grade Serous Ovarian Carcinoma
per: Cuiping Li, et al.
Publicat: (2022-06-01)

Treatment results and prognostic factors of clear cell ovarian carcinomas and ovarian carcinomas with clear cell component
per: M. D. Ahmedova, et al.
Publicat: (2014-07-01)

Acute Presentation of Large Size Clear Cell Ovarian Carcinoma as Double Torsed Ovarian Tumor
per: Diana Bužinskienė, et al.
Publicat: (2022-01-01)

Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin
per: Akira Nishijima, et al.
Publicat: (2024-08-01)

Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study
per: Eun-Gyeong Lee, et al.
Publicat: (2023-09-01)

Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas
per: Huann-Cheng Horng, et al.
Publicat: (2014-12-01)

Fallopian tube origin of supposed ovarian high-grade serous carcinomas
per: Patricia Martini Diniz, et al.
Publicat: (2011-01-01)

Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
per: Ling Zhou, et al.
Publicat: (2021-05-01)

Immunoexpression of p53 and p16 in Low and High-grade Serous Ovarian Cancer: A Cross-sectional Study
per: Ranajit Mandal, et al.
Publicat: (2023-11-01)

Correction of Funding information: The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999–2017: Korea Central Cancer Registry
per: Hyeong In Ha, et al.
Publicat: (2022-07-01)

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
per: Li Jie, et al.
Publicat: (2012-03-01)

Ovarian clear cell carcinoma with bilateral breast metastasis
per: Aashita, et al.
Publicat: (2023-01-01)

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
per: Martin Köbel, et al.
Publicat: (2023-05-01)

Ovarian high-grade serous carcinoma with estrogenic manifestations in a postmenopausal woman: A case report
per: Akihiro Takeda, et al.
Publicat: (2023-03-01)

Proteomic Analysis of Matched Formalin-Fixed, Paraffin-Embedded Specimens in Patients with Advanced Serous Ovarian Carcinoma
per: Ashlee L. Smith, et al.
Publicat: (2013-10-01)

Intra-Tumoral Lymphocytic Infiltration Is Associated with Favorable Prognosis in Suboptimal Surgery in High-Grade Serous Ovarian Carcinoma
per: Hiroshi Harada, et al.
Publicat: (2025-02-01)

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
per: Takuma Ohsuga, et al.
Publicat: (2017-08-01)

Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
per: Tsukuru Amano, et al.
Publicat: (2021-01-01)

Importance of serous intraepithelial ovarian tubal carcinomas in the occurrence of "high-grade" serous carcinomas and / or peritoneal serous carcinomas of unknown primary origin.
per: I. S. Shponka, et al.
Publicat: (2020-04-01)

Tryptophan metabolism enzymes are potential targets in ovarian clear cell carcinoma
per: Sumei Zhang, et al.
Publicat: (2023-12-01)

Ovarian clear cell carcinoma with uterine intramural recurrence: Case report of ovarian clear cell carcinoma with fertility sparing treatment
per: Ting Yu Chang, et al.
Publicat: (2024-01-01)

High-Grade Serous Carcinoma Resulting From Rectal Endometriosis and Complicated With Ovarian Cancer
per: Li Song, et al.
Publicat: (2019-11-01)

High-throughput approaches for precision medicine in high-grade serous ovarian cancer
per: Meinusha Govindarajan, et al.
Publicat: (2020-10-01)

Serous ovarian carcinoma. Cytological and immunocytochemical and molecular genetic diagnostics
per: O. G. Grigoruk, et al.
Publicat: (2016-09-01)

Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters
per: Sofia Westbom-Fremer, et al.
Publicat: (2025-01-01)

Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
per: Se Ik Kim, et al.
Publicat: (2022-09-01)

Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma
per: Kristina Mae Bienes, et al.
Publicat: (2025-01-01)

Changes in ovarian cancer survival during the 20 years before the era of targeted therapy
per: Jung-Yun Lee, et al.
Publicat: (2018-05-01)

Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
per: Wenwen Chien, et al.
Publicat: (2023-04-01)

A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma
per: Kazuya Maeda, et al.
Publicat: (2018-08-01)

Concordance of HER2 Expression in Paired Primary and Metastatic Sites of Endometrial Serous Carcinoma and the Effect of Intratumoral Heterogeneity
per: Francis Hong Xin Yap, et al.
Publicat: (2024-09-01)

The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma
per: Shuang Ye, et al.
Publicat: (2022-04-01)